
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : CDT1656
Therapeutic Area : Immunology
Study Phase : Phase I
Sponsor : Conduit Pharma
Deal Size : Undisclosed
Deal Type : Partnership
Conduit, Agility Life Sciences Collaborate on Autoimmune Pipeline Formulations
Details : The partnership aims to develop new solid oral-dosage form products of its autoimmune pipeline for use in future clinical trials, which includes CDT1656 for treating autoimmune diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
January 22, 2025
Lead Product(s) : CDT1656
Therapeutic Area : Immunology
Highest Development Status : Phase I
Sponsor : Conduit Pharma
Deal Size : Undisclosed
Deal Type : Partnership

Contact Us!